Summary MSDx, Inc. (MSDx) is a medical device company that provides blood testing products for brain diseases. The company offers diagnosis, monitoring, and assessing therapeutics response. It provides data that can be useful in monitoring, diagnosis, and assessing therapeutics response. MSDx's window into the brain blood test panel offers a real-time view of pathological processes and disease activity in the brain. The company's assays can be tested both individually and as a panel for diagnosis and management of patients. It also provides leukocyte transmigration, neurodegenerative, and demyelination biomarkers. The company also offers Blood Based Biochemical Monitoring of Major Diseases of the CNS and Exploiting Immunophysiology to retrieve information. MSDx is headquartered in Tucson, Arizona, the US. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company MSDx, Inc. - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date. Reasons to Buy: - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 4 MSDx, Inc. Company Snapshot 5 MSDx, Inc. Company Overview 5 MSDx, Inc. Pipeline Products and Clinical Trials Overview 6 MSDx, Inc. - Pipeline Analysis Overview 8 Key Facts 8 MSDx, Inc. - Major Products and Services 9 MSDx, Inc. Pipeline Products by Development Stage 10 MSDx, Inc. Pipeline Products Overview 12 Diagnostic Test - Active Demyelination 12 Diagnostic Test - Active Demyelination Product Overview 12 Diagnostic Test - Active Neurodegeneration 13 Diagnostic Test - Active Neurodegeneration Product Overview 13 Diagnostic Test - PBMCs 14 Diagnostic Test - PBMCs Product Overview 14 MSDx Complex-1 Diagnostic Test 15 MSDx Complex-1 Diagnostic Test Product Overview 15 NK Cytolytic Competence Assay Kit 16 NK Cytolytic Competence Assay Kit Product Overview 16 MSDx, Inc. - Key Competitors 17 MSDx, Inc. - Key Employees 18 MSDx, Inc. - Locations And Subsidiaries 19 Head Office 19 Recent Developments 20 MSDx, Inc., Recent Developments 20 Sep 17, 2013: MSDx Announces Issuance of First Patent for Monitoring Disease Activity in a Multiple Sclerosis Patient 20 Jan 02, 2012: MSDx Launches Clinical Study In Multiple Sclerosis With Northwest NeuroSpecialists 20 Oct 21, 2011: MSDx Presents Research Results At ECTRIMS/ACTRIMS Conference 20 May 17, 2011: MSDx Receives $226,000 Arizona Commerce Authority Grant 21 Appendix 22 Methodology 22 About GlobalData 22 Contact Us 22 Disclaimer 22
List of Tables
MSDx, Inc. Pipeline Products and Clinical Trials Overview 6 MSDx, Inc. Pipeline Products by Equipment Type 6 MSDx, Inc. Pipeline Products by Indication 7 MSDx, Inc., Key Facts 8 MSDx, Inc., Major Products and Services 9 MSDx, Inc. Number of Pipeline Products by Development Stage 10 MSDx, Inc. Pipeline Products Summary by Development Stage 11 Diagnostic Test - Active Demyelination - Product Status 12 Diagnostic Test - Active Demyelination - Product Description 12 Diagnostic Test - Active Neurodegeneration - Product Status 13 Diagnostic Test - Active Neurodegeneration - Product Description 13 Diagnostic Test - PBMCs - Product Status 14 Diagnostic Test - PBMCs - Product Description 14 MSDx Complex-1 Diagnostic Test - Product Status 15 MSDx Complex-1 Diagnostic Test - Product Description 15 NK Cytolytic Competence Assay Kit - Product Status 16 NK Cytolytic Competence Assay Kit - Product Description 16 MSDx, Inc., Key Employees 18
List of Figures
MSDx, Inc. Pipeline Products by Equipment Type 7 MSDx, Inc. Pipeline Products by Development Stage 10
U.S hairbrush market is estimated to exceed USD 1.2 billion by 2022, as per a new research report by Radiant Insights, Inc. Rising population along with ascending disposable income is expected to drive industry demand. Significant rise in disposableRead More...
Global engineering service outsourcing market size is likely to be valued at USD 415.7 billion by 2020, as per a new research report by Radiant Insights, Inc. Rapid alignment of OEMs accompanied by increasing focus on efficient performance and reliabRead More...
North America air conditioner market size is expected to be valued at USD 52,560.7 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing usage of energy efficient air conditioners owing to declining energy consumption ratRead More...
Global electric water heaters market is expected to be valued at USD 29,322.4 million by 2022, as per a new research report by Radiant Insights, Inc. Escalating demand across extensive range of domestic applications is expected to drive demand. EvolvRead More...
Global Automated Test Equipment (ATE) market is expected to be valued at USD 4.48 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing design complexity coupled with need for effective testing is expected to drive the glRead More...
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.